Cargando…
The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles
Since the demonstration of its involvement in cell proliferation, the eukaryotic initiation factor 5A (eIF5A) has been studied principally in relation to the development and progression of cancers in which the isoform A2 is mainly expressed. However, an increasing number of studies report that the i...
Autores principales: | Tauc, Michel, Cougnon, Marc, Carcy, Romain, Melis, Nicolas, Hauet, Thierry, Pellerin, Luc, Blondeau, Nicolas, Pisani, Didier F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705083/ https://www.ncbi.nlm.nih.gov/pubmed/34952646 http://dx.doi.org/10.1186/s13578-021-00733-y |
Ejemplares similares
-
Inhibition of eIF5A hypusination reprogrammes metabolism and glucose handling in mouse kidney
por: Cougnon, Marc, et al.
Publicado: (2021) -
Renal Ischemia Tolerance Mediated by eIF5A Hypusination Inhibition Is Regulated by a Specific Modulation of the Endoplasmic Reticulum Stress
por: Melis, Nicolas, et al.
Publicado: (2023) -
Akt Inhibition as Preconditioning Treatment to Protect Kidney Cells against Anoxia
por: Melis, Nicolas, et al.
Publicado: (2021) -
Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy
por: Bourourou, Miled, et al.
Publicado: (2020) -
LRRC8/VRAC channels exhibit a noncanonical permeability to glutathione, which modulates epithelial-to-mesenchymal transition (EMT)
por: Friard, Jonas, et al.
Publicado: (2019)